The power analysis was performed using GPower version 3.1 (Heinrich-Heine University, Dsseldorf, Germany)
From a practical standpoint, individuals using GLP-1-based therapies (the approved class most pharmacologically similar to retatrutide) are increasingly advised by clinicians to: Maintain adequate dietary protein intake general guidance from sports nutrition and dietetic sources suggests approximately 1.21.6 g per kg of body weight per day for those undertaking resistance exercise, though this should be individualised with a dietitian or clinician, particularly for older adults or those with kidney disease Engage in regular resistance exercise to preserve muscle tissue Consider evidence-based supplements such as creatine, under medical supervision Whilst the specific combination of creatine and retatrutide has not been studied in clinical trials, the rationale for using creatine to support muscle preservation during weight loss is scientifically sound
Follow the label, pharmacy directions, and clinician instructions for storage, titration, and beyond-use dates
Often chosen by women who have plateaued on another GLP-1
Youre only thinking about the scale
Identifying the cause + early treatment helps prevent long-term complications
